Advertisement

World Journal of Surgery

, Volume 43, Issue 3, pp 937–943 | Cite as

Opportunity Lost? Diagnostic Laparoscopy in Patients with Pancreatic Cancer in the National Surgical Quality Improvement Program Database

  • Munizay Paracha
  • Kathryn Van Orden
  • Gregory Patts
  • Jennifer Tseng
  • David McAneny
  • Teviah SachsEmail author
Original Scientific Report
  • 56 Downloads

Abstract

Background

Routine preoperative staging in pancreas cancer is controversial. We sought to evaluate the rates of diagnostic laparoscopy (DLAP) for pancreatic cancer.

Methods

We queried the National Surgical Quality Improvement Program for patients with pancreas cancer (2005–2013) and compared groups who underwent DLAP, exploratory laparotomy (XLAP), pancreas resection (RSXN) or therapeutic bypass (THBP). We compared demographics, comorbidities, postoperative complications, 30-day mortality (Chi-square P < 0.05) and trends over time (R2 0–1).

Results

We identified 17,138 patients (RSXN 81.8%, XLAP 16.5%, THBP 8.2%, and DLAP 12.9%), with some having multiple CPT codes. Only 10.3% (n = 1432) of RSXN patients underwent DLAP prior to resection. XLAP occurred in 49.5% of non-RSXN patients, of whom 67.1% had no other operation. The percentage of patients undergoing RSXN increased 20.3% over time (R2 0.81), while DLAP decreased 52.6% (R2 0.92). XLAP patients without other operations decreased from 4.2 to 2.4%, although not linearly (R2 0.31). Only 10.3% of XLAP had a diagnostic laparoscopy as well, leaving nearly 90% of these patients with an exploratory laparotomy without RSXN or THBP.

Discussion

Diagnostic laparoscopy for pancreas malignancy is becoming less common but could benefit a subset of patients who undergo open exploration without resection or therapeutic bypass.

References

  1. 1.
    US Cancer Statistics Working Group (2017) United States Cancer Statistics: 1999–2014 incidence and mortality web-based report. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. www.cdc.gov/uscs. Accessed 12 Apr 2018
  2. 2.
    Maithel S, Maloney S, Winston C, Gonen M, D’Angelica MI, Dematteo RP et al (2008) Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol 15:3512–3520CrossRefGoogle Scholar
  3. 3.
    Soriano A, Castells A, Ayuso C, de Caralt MT, Gines MA, Real MI et al (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99:492–501CrossRefGoogle Scholar
  4. 4.
    Valls C, Andia E, Sanchez A, Fabregat J, Pzuelo O, Quintero JC et al (2002) Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. Am J Roentgenol 178:821–826CrossRefGoogle Scholar
  5. 5.
    Howard T, Chin AC, Streib EW, Kopecky KK, Wiebke EA (1997) Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg 174:237–241CrossRefGoogle Scholar
  6. 6.
    Levy J, Tahiri M, Vanounou T, Maimon G, Bergman S (2016) Diagnostic laparoscopy with ultrasound still has a role in the staging of pancreatic cancer: a systematic review of the literature. HPB Surg 2016:8092109CrossRefGoogle Scholar
  7. 7.
    White R, Winston C, Gonen M, D’Angelica M, Jarnagin M, Fong Y et al (2008) Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 206:445–450CrossRefGoogle Scholar
  8. 8.
    Mayo S, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG (2009) Evolving preoperative evaluation of patients with pancreatic cancer: Does laparoscopy have a role in the current era? J Am Coll Surg 208:87–95CrossRefGoogle Scholar
  9. 9.
    De Rosa A, Cameron I, Gomez D (2016) Indications for staging laparoscopy in pancreatic cancer. HPB 18:13–20CrossRefGoogle Scholar
  10. 10.
    Beenen E, van Roest M, Sieders E, Peeters PM, Porte RJ, de Boer MT, de Jong KP (2014) Staging laparoscopy in patients scheduled for pancreaticoduodenectomy minimizes hospitalization in the remaining life time when metastatic carcinoma is found. EJSO 40:989–994CrossRefGoogle Scholar
  11. 11.
    McNack M, Sptiz J, Arregui M (2001) Staging of pancreatic and ampullary cancers for resectability using laparoscopy with laparoscopic ultrasound. Surg Endosc 15:1129–1134CrossRefGoogle Scholar
  12. 12.
    Morris S, Gurusamy K, Sheringham J, Davidson BR (2015) Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer. BMC Gastroenterol 15:1–8CrossRefGoogle Scholar
  13. 13.
    Peng J, Mino J, Monteiro R, Morris-Stiff G, Ali NS, Wey J et al (2017) Diagnostic laparoscopy prior to neoadjuvant therapy in pancreatic cancer is high yield: an analysis of outcomes and costs. J Gastrointest Surg 21:1420–1427CrossRefGoogle Scholar
  14. 14.
    Velanovich V, Wollner I, Ajluni M (2000) Staging laparoscopy promotes increased utilization of postoperative therapy for unresectable intra-abdominal malignancies. J Gastrointest Surg 4:542–546CrossRefGoogle Scholar
  15. 15.
    Morris S, Gurusamy KS, Sheringham J, Davidson BR (2015) Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer. BMC Gastroenterol 2(15):44CrossRefGoogle Scholar
  16. 16.
    Jarnagin W, Bodniewicz J, Dougherty E, Conlon K, Blumgart LH, Fong Y (2000) A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg 4:34–42CrossRefGoogle Scholar
  17. 17.
    D’angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K, Blumgart LH, Jarnagin WR (2003) The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 10(2):183–189CrossRefGoogle Scholar
  18. 18.
    Allen VB, Gurusamy KS, Takwoingi Y, Kalia A, Davidson BR (2016) Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev 6:7Google Scholar
  19. 19.
    Alexakis N, Gomatos I, Sbarounis S, Toutouzas K, Katsaragakis S, Zografos G, Konstandoulakis MM (2014) High serum CA 19-9 but not tumor size should select patients for staging laparoscopy in radiological resectable pancreas head and periampullary cancer. EJSO 41:265–269CrossRefGoogle Scholar
  20. 20.
    Schnelldorfer T, Gagnon A, Birkett R, Reynolds G, Murphy KM, Jenkins RL (2014) Staging laparoscopy in pancreatic cancer: a potential role for advanced laparoscopic techniques. J Am Coll Surg 218:1201–1206CrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2018

Authors and Affiliations

  • Munizay Paracha
    • 1
  • Kathryn Van Orden
    • 1
  • Gregory Patts
    • 2
  • Jennifer Tseng
    • 1
  • David McAneny
    • 1
  • Teviah Sachs
    • 1
    • 3
    Email author
  1. 1.Department of SurgeryBoston University School of MedicineBostonUSA
  2. 2.Boston University School of Public HealthBostonUSA
  3. 3.Department of Surgical OncologyBoston Medical CenterBostonUSA

Personalised recommendations